Physician profile
Sreenivas Avula
NPI 1154634566
$727.44
in general payments reported to CMS, 2019-2025
6 companies · $22.32 in 2025
The $22.32 reported for 2025 was less than what a typical Neurology With Special Qualifications In Child Neurology provider received nationally (typical 2025 total: $275).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2021: $12.60 · 2022: $287 · 2023: $224 · 2024: $56.61 · 2025: $22.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $303.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $366.18 | 2022-2023 | Assure Wcd |
| Sarepta Therapeutics, INC. | $186.58 | 2023-2024 | Elevidys, Vyondys 53 |
| Biogen, INC. | $124.57 | 2019 | |
| Livanova USA, INC. | $22.32 | 2025 | Vns Therapy Sentiva Model 1000 Generator |
| Aquestive Therapeutics, INC. | $15.19 | 2022 | |
| Zogenix INC. | $12.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sreenivas Avula listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.